RAPT Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2020 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: RAPT Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2020 to Q3 2024.
RAPT Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 782 %, a 35.2% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	782	-424	-35.2%	Sep 30, 2024
Q2 2024	776	-595	-43.4%	Jun 30, 2024
Q1 2024	878	-546	-38.4%	Mar 31, 2024
Q4 2023	980	-580	-37.2%	Dec 31, 2023
Q3 2023	1.21K	-379	-23.9%	Sep 30, 2023
Q2 2023	1.37K	-288	-17.4%	Jun 30, 2023
Q1 2023	1.42K	-376	-20.9%	Mar 31, 2023
Q4 2022	1.56K	-124	-7.35%	Dec 31, 2022
Q3 2022	1.59K	+149	+10.3%	Sep 30, 2022
Q2 2022	1.66K	+489	+41.8%	Jun 30, 2022
Q1 2022	1.8K	+870	+93.5%	Mar 31, 2022
Q4 2021	1.68K	+711	+73%	Dec 31, 2021
Q3 2021	1.44K	+485	+51%	Sep 30, 2021
Q2 2021	1.17K	+164	+16.3%	Jun 30, 2021
Q1 2021	931			Mar 31, 2021
Q4 2020	973			Dec 31, 2020
Q3 2020	952			Sep 30, 2020
Q2 2020	1.01K			Jun 30, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.